Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 14, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics.
The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish a next-generation sequencing (NGS) laboratory. The lab will focus on accelerating access to early cancer detection and molecular residual disease (MRD) monitoring using AI-powered circulating tumor DNA (ctDNA) technologies, tailored to address the unique clinical needs of southern China's healthcare landscape.
USKBio brings extensive expertise in Polymerase Chain Reaction (PCR) -based In Vitro Diagnostics (IVD) and Good Manufacturing Practice (GMP)-certified production capabilities. Gene Solutions contributes its leadership in NGS-based oncology applications, highlighted by its groundbreaking SPOT-MAS test — Asia's first clinically validated multi-cancer early detection (MCED) assay, validated through a prospective study of 9,024 participants. Additionally, Gene Solutions recently published a real-world MRD study involving 623 patients across six cancer types—lung, colorectal, breast, gastric, liver, and ovarian—demonstrating the clinical utility of ctDNA for monitoring treatment response and assessing recurrence risk.
This partnership will focus on localizing and validating these cutting-edge technologies for the Chinese market while fostering joint R&D and production of advanced IVD medical devices. This alliance represents a major step forward in delivering accessible, high-impact, personalized cancer diagnostics to a broader population in China.
"This partnership with USKBio allows us to move quickly in establishing a high-impact oncology hub in southern China," said Dr. Nguyen Hoai Nghia, CEO and Co-founder at Gene Solutions. "Together, we aim to bring early, accurate, and scalable cancer screening and diagnostics to more patients, ultimately improving cancer outcomes."
"Gene Solutions and USKBio are highly complementary in their core technologies, regional markets, and business models." said Dr. Yu Dehua, CEO at USKbio. "This strategic collaboration will leverage both parties' strengths, creating strong synergies to deliver greater benefits to cancer patients across the Asia region."
The partnership also includes technology transfer, technical training, and joint commercialization efforts to ensure rapid deployment and widespread adoption of these advanced genomic tools.
About Shenzhen USKBio
Founded in August 2015, Shenzhen USKBio is a national high-tech biological enterprise established by leading Chinese and American scientists and entrepreneurs. Specializing in in vitro molecular diagnostics, USKBio integrates R&D, production, marketing, and medical testing services, with a robust presence in IVD reagents, diagnostic instruments, and testing services. Leveraging proprietary technologies such as Udx-PCR and Udx-MSP, the company offers innovative solutions for early cancer screening, precision diagnosis, and companion diagnostics. With over 36 authorized patents and collaborations across top hospitals and testing institutions in China, USKBio is a rising leader in the global molecular diagnostics industry, dedicated to advancing precision medicine.
About Gene Solutions
Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring.
With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. https://genesolutions.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
37 minutes ago
- Korea Herald
Gene Solutions Strengthens China Footprint with Strategic Partnerships in Precision Oncology
BEIJING, June 20, 2025 /PRNewswire/ -- Gene Solutions announces the signing of two strategic Memoranda of Understanding (MOUs) with ZaoDx and Xiong'an MagicBiotech Co., Ltd. These partnerships mark a focused expansion of Gene Solutions' precision oncology efforts into the Chinese market through collaborative technology introduction, research exploration, and localized deployment of its innovative cancer testing platforms. Together, the partnerships reinforce Gene Solutions' long-term commitment to supporting China's healthcare innovation ecosystem with advanced, clinically validated tools for early cancer detection and monitoring. Enabling Early Detection Through Ecosystem Engagement with ZaoDx Gene Solutions and ZaoDx have formed a strategic business alliance to jointly explore the introduction, promotion, and responsible commercialization of advanced early cancer screening technologies in China. This partnership will focus on: CEO of ZaoDx Dr. Chen Zanquan stated: "Cancer is a challenge faced globally, and early detection is crucial for cure. ZAODX is pleased to collaborate with Gene Solutions to advance the conversion and accessibility of innovative cancer screening and diagnosis technologies. I believe our joint efforts will bring tangible benefits to millions of families." "Our collaboration with ZaoDx reflects a shared commitment to bringing global innovation into meaningful local impact," said Jiang Hao, Business Development Manager at Gene Solutions. "By working alongside respected research-driven partners, we can responsibly introduce early detection technology to more patients and providers across the country." Advancing Research Collaboration in Northern China alongside MagicBiotech Gene Solutions and Xiong'an MagicBiotech have signed an MOU to jointly explore the introduction and academic evaluation of next-generation sequencing (NGS)–based oncology technologies across northern China. The collaboration will center on: "Our partnership with MagicBiotech is a cornerstone for advancing precision oncology in China," said Ida Deleskog Lindstrom, Global Medical Affairs Director at Gene Solutions. "By fostering collaborative research and leveraging local expertise, we aim to validate and scale our technologies to meet the region's clinical and scientific needs." Driving Localized Innovation Through Strategic Collaboration These dual partnerships represent a calibrated approach by Gene Solutions to support the introduction and validation of advanced oncology diagnostics in China. Both collaborations are built on mutual strengths—balancing scientific rigor, ethical commercialization, and long-term research-driven engagement. Project-specific initiatives under each MOU will be rolled out progressively in alignment with local regulations and institutional priorities. About ZaoDx ZAODX Early Screening Network is a globally leading platform dedicated to the early detection of diseases, with a core mission to drive the transformation of global healthcare systems from treatment-centric models to a proactive, health-centered paradigm. Guided by the widely recognized principle that "prevention is the most cost-effective and impactful health strategy," ZAODX advocates the global adoption of early screening, early diagnosis, and early treatment — while also drawing inspiration from Traditional Chinese Medicine's wisdom of "treating disease before it occurs." As a truly international and multidisciplinary team, ZAODX brings together key stakeholders across the global healthcare ecosystem — including scientists, entrepreneurs, investors, policymakers, healthcare providers, and public health experts — united by the mission to make health screening accessible and equitable for all. The network has established strategic partnerships with over 1,000 top-tier medical institutions, academic organizations, professional societies, independent laboratories, and healthcare innovators to foster cross-border academic exchange, scientific collaboration, technology translation, industry synergy, and public health education. Committed to global public health goals, ZAODX actively supports initiatives led by the World Health Organization and national health authorities. Through collaborative efforts, ZAODX is building an innovative and inclusive early screening ecosystem — empowering the global fight for earlier prevention, better outcomes, and healthier populations worldwide. About Xiong'An MagicBiotech Xiong'An MagicBiotech is a biotechnology company in Xiongan New Area focusing on "in vitro diagnostic reagents + testing services + artificial intelligence". MagicBiotech is mainly engaged in independent research and development, production and sales of in vitro diagnostic kits for genetic testing. By using multi-omics medical examination data and bioinformatics AI artificial intelligence technology, it provides in vitro diagnostic reagents and medical testing services to medical institutions and patients; in the scientific research and technology service sector, MagicBiotech has always adhered to the concept of innovation-driven, continued to increase R&D investment, and made every effort to build a complete and advanced technology platform system. The system deeply covers cutting-edge fields such as genomics, proteomics, metabolomics, microbiome, and single-cell multi-omics. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific.
Korea Herald
3 hours ago
- Korea Herald
EV battery recycling heats up in Korea despite market slump
Industry eyes rebound by 2030 as used batteries pile up, global recycling mandates kick in Korea's industry giants are stepping up their involvement in the electric vehicle battery recycling sector, signaling expectations that the currently subdued industry will evolve into a critical component of the battery value chain. LG Energy Solution, Korea's largest battery maker, recently formed joint ventures in Europe and the US — with France's Derichebourg and Toyota Tsusho Co., respectively — marking its first direct steps into battery recycling operations in both regions. SK Ecoplant, a construction engineering unit of SK Group, is expanding its European facility in the Netherlands to add 25,000 metric tons of annual black mass processing capacity, with completion scheduled for 2025. Posco-GS Eco Materials, a 51:49 joint venture between Posco Holdings and GS Energy, acquired full control of its battery recycler, Posco HY Clean Metal, by purchasing the 35 percent stake held by China's Huayou Cobalt in April. 'It is late compared to other countries' battery industries, as even Chinese companies such as CATL have their own recycling business,' said Park Cheol-wan, a car engineering professor at Seojeong University. 'Yet it is the right path for Korean companies, as securing a stable supply chain for minerals will become increasingly significant.' These moves come as the battery recycling sector continues to suffer a deep slump, driven by sluggish EV demand and sharp declines in the prices of key battery minerals such as nickel, lithium and manganese. International lithium carbonate prices, which were above 450 Chinese yuan ($63) per kilogram in January 2023, have fallen to around 50 yuan. Nickel prices also dropped significantly, from over $31,000 per ton to around $20,000. As a result, SungEel HiTech, one of only two battery recycling companies listed on Korea's tech-focused Kosdaq, has experienced declines in profitability and free cash flow for two consecutive years. A joint battery recycling project between SungEel HiTech and SK Innovation, announced in 2022, has been indefinitely delayed, while SK Ecoplant's planned facilities in Gyeongju, North Gyeongsang Province, and Kentucky have also shown no signs of progress for years. The industry, however, anticipates a significant increase in the number of used EV batteries as they reach the end of their life cycle, which is estimated to be around 10 years. This follows the surge in global EV sales in the 2010s, which surpassed one million units in 2015. With the continued growth of EV adoption, the battery recycling market — valued at $8 billion in 2022 — is projected to expand to as much as $53.57 billion by 2030, according to SNE Research. Experts say that entering the battery recycling business is increasingly becoming essential for staying competitive in the battery industry, as global policy trends push for recycled minerals to be a core component of battery supply chains. The European Union requires all EV batteries placed within the region to meet minimum recycled metal content thresholds by 2031: 16 percent for cobalt, 85 percent for lead, 6 percent for lithium and 6 percent for nickel. These requirements will increase by 2036. Meanwhile, EVs with some key battery components or minerals sourced from foreign entities of concern are excluded from US tax credits under the Inflation Reduction Act, pressuring battery makers to secure materials domestically, often through recycling. 'It is more a matter of broader business strategy than the profitability of recycling itself, whether companies choose to outsource recycled materials or secure them in-house,' Park added. '(With policy changes in place,) it may become faster to secure used batteries rather than invest in new mines, exploration, refining and metal procurement. To ensure a stable supply of critical minerals, battery makers will be competing as if at war.'
Korea Herald
4 hours ago
- Korea Herald
LPS and QAX Announce Strategic Partnership for Cybersecurity, Unveiling Security Operation Centre and End-to-End Security Services
HONG KONG, June 20, 2025 /PRNewswire/ -- Lenovo PCCW Solutions (LPS) announces the launch of the first Security Operation Centre (SOC) in collaboration with leading Chinese cybersecurity firm, Qi An Xin Technology Group (QAX), aiming to address a critical market need for end-to-end managed security operation services to combat increasingly complex cyber threats. Powered by QAX's advanced threat detection and prevention technologies, as well as its global threat intelligence capabilities, alongside LPS' industry leading managed services, the SOC is located in Hong Kong and offers 24/7 security operation services. The SOC will empower enterprises to embrace AI technologies while ensuring compliance and fortified protection. The Asia-Pacific region is a major hotspot for cyberattacks due to the rapid proliferation of digital technology, with the largest recorded data breach to date costing up to USD 20 million [1]. Hong Kong experienced a similarly alarming trend in 2025, as the Hong Kong Computer Emergency Response Team Coordination Centre (HKCERT) reported a 67% [2] year-on-year increase in cybersecurity incidents during the first quarter alone. The city's regulatory framework has been growing in response, with standards like the Protection on Critical Infrastructures (Computer Systems) Bill, the Insurance Authority's revised Guideline on Cybersecurity (GL20), and the updated Government IT Security Guideline (G3) requiring organizations to strengthen cybersecurity defences, enhance employee awareness, and align with compliance frameworks to mitigate risks. The strategic partnership integrates advanced AI-powered threat detection with human expertise to deliver comprehensive cybersecurity protection for enterprises. Key features include offensive and defensive security services, along with a security dashboard that visually presents vulnerabilities, attacker behavior, and overall risk levels – enabling enterprises to better understand and manage their security risk. LPS' expertise in Hong Kong's IT ecosystem and unique cross-industry knowledge will be an invaluable asset for enterprises faced with the unique challenges of the dynamic cybersecurity landscape. "With the accelerating pace of digital transformation and the rise of cyber threats, the demand for secure and resilient digital ecosystems is greater than ever before. Our SOC will address the critical need for advanced cybersecurity solutions." said Dr. Ted Suen, President of LPS, further elaborating that, "LPS is committed to collaborating with cybersecurity leaders like QAX to integrate advanced emerging technologies, actionable threat intelligence, and extensive industry expertise into our security offerings, empowering enterprises to navigate the digital age with safety and confidence." Meanwhile, QAX boasts a proven track record of defending against high-profile cyberattacks – including at the 2022 Beijing Winter Olympics where they successfully achieved zero incidents. QAX's cybersecurity specialists also possess comprehensive capabilities for mitigating security risks in large language models (LLM), providing enterprises with enhanced protection through their proprietary LLM security solution. Qi Xiangdong, Chairman of QAX Group, said: "Our partnership with LPS to launch the first SOC in Hong Kong reflects our shared dedication to protect clients' valuable assets and data. QAX will work together with partners, leveraging proprietary technologies and years of accumulated expertise in safeguarding national projects to advance the implementation of cybersecurity technologies, enhance localized operations and service capabilities, and provide enterprises with robust tools to navigate an increasingly complex and dynamic threat landscape." The establishment of the SOC heralds a new era for cybersecurity in Hong Kong, offering a comprehensive, 24/7 shield against cyber threats. LPS will continue to enhance its security services as a trusted digital advisor and look to build on this milestone partnership with QAX to drive secure growth and digital transformation for clients across the Asia Pacific region. About Lenovo PCCW Solutions (LPS) LPS is a leading IT and technology solutions provider in the Asia Pacific region. We partner with governments and enterprises to achieve digital transformation excellence, driving business growth through our market-leading solutions and industry best practices. As a proud member of Lenovo Group, we have unlocked new synergies with Lenovo's global reach and technological capabilities, focusing on AI, data practice, cloud and cybersecurity. With our 4,000+ team of domain experts and a strong network of ecosystem partners, LPS is committed to providing cutting-edge AI-powered solutions and data best practices to enable organizations to excel in their digital journey. About QAX Technology Group QAX is the largest cybersecurity company based in China, and a leader in cybersecurity industry, providing new generation enterprise - level and national - level cybersecurity solutions. Years of R&D and innovation accumulated from cyber offense and defence practice, QAX has reinforced the strength in big data, AI, machine learning and security operation. As the official cybersecurity services and anti - virus software sponsor of the Olympic and Paralympic Winter Games Beijing 2022, QAX successfully secured the Olympic - Games with zero - cyber incident.
